Supplementary Figure 3: The proportion of mVHH-IgA in the different feed formulations fed to the piglets. | Nature Biotechnology

Supplementary Figure 3: The proportion of mVHH-IgA in the different feed formulations fed to the piglets.

From: Yeast-secreted, dried and food-admixed monomeric IgA prevents gastrointestinal infection in a piglet model

Supplementary Figure 3

Equal part mix of mVHH-IgA V2A and V3A in the final feed formulations either secreted from Pichia (Pichia mVHH-IgA feed), or produced in soybean (soybean mVHH-IgA feed) or Arabidopsis (Arabidopsis mVHH-IgA feed) were analyzed as compared to negative control feed without mVHH-IgA. (a) Immunoblot of 10% (w/v) feed suspension extracts which were pre-treated with Endo H. The volume of feed extract loaded corresponds to 1.2 mg of each feed formulation. The densitometric analysis on the ~ 37 kDa band, using the purified Endo H treated Pichia-secreted V2A dilution series as reference standards, corresponded to be 0.0011% for Pichia feed (3.3 mg in 300 gram daily feed), 0.0025% for soybean feed (7.5 mg in 300 gram daily feed) and 0.0013% for Arabidopsis feed (3.9 mg in 300 gram daily feed). (b, c) ELISA titration curves of the 10% (w/v) suspensions of all the experimental feed formulations containing mVHH-IgA (b) without Endo H pre-treatment and (c) with Endo H pre-treatment. In the latter case, the yeast N-glycan mediated inhibition of mVHH-IgA detectability in ELISA is eliminated, resulting in the curves and the endpoint titers as very similar. These analysis were repeated at least twice with similar results.

Back to article page